Biodesix Inc
BDSX
Market Cap$80.14M
Close$
Share Statistics
| Market cap | $80.14 Million |
|---|---|
| Enterprise Value | $116.55 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.33 |
| Beta | 1.16 |
| Outstanding Shares | 129,670,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.66 |
|---|---|
| PEG | 26.27 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.78 |
| Enterprise Value to EBIT | -3.37 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.54 |
| Debt to Equity | 3 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Biodesix Inc
200 employeesBiodesix, Inc. operates as a biotechnology company. The Company offers non-small cell lung cancer pretreatment serum tests and laboratory testing. Biodesix provides diagnostic tools and equipment for blood and tissue analysis in the United States.